MedTrace Logo

Assessment of an Automatic Closed-loop Insulin Delivery System

NCT02366767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2017-03-17

Study results available
· View outcomes & findings →

Summary

The overall aim of this research proposal is to determine the safety, feasibility and efficacy of an automatic closed-loop insulin delivery system.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DEVICE

Automatic closed-loop insulin delivery

Sensor transmit glucose data every 5 minutes to the control algorithm which adjusts insulin delivery every 5 minutes.

DEVICE

Control

Threshold suspend

Sponsors & Collaborators

Principal Investigators

  • Bruce Buckingham, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02366767 on ClinicalTrials.gov